Participation and Crowd-Out in a Medicare Drug Benefit: Simulation Estimates

Dennis G. Shea, Bruce C. Stuart, Becky Briesacher

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

This article provides information on likely participation in the Medicare prescription drug plan and expected crowd-out. We use a microsimulation model based on data from the MCBS to estimate the costs and benefits of a Medicare drug plan, including the benefits from reductions in risk. The simulations are repeated using different combinations of benefits and subsidies. In addition, the simulations explore the effects of different behavioral parameters for moral hazard (the extent to which participants increase drug spending in response to reduced costs) and risk aversion (the extent to which participants would be willing to pay to avoid risk) to identify the impact of these factors on participation and crowd-out.

Original languageEnglish (US)
Pages (from-to)47-61
Number of pages15
JournalHealth Care Financing Review
Volume25
Issue number2
StatePublished - Dec 2003

Fingerprint

Medicare
Pharmaceutical Services Insurance
drug
simulation
participation
Prescription Drugs
Risk Reduction Behavior
Pharmaceutical Preparations
Cost-Benefit Analysis
costs
Costs and Cost Analysis
subsidy
medication

All Science Journal Classification (ASJC) codes

  • Nursing(all)
  • Health(social science)
  • Health Professions(all)

Cite this

Shea, Dennis G. ; Stuart, Bruce C. ; Briesacher, Becky. / Participation and Crowd-Out in a Medicare Drug Benefit : Simulation Estimates. In: Health Care Financing Review. 2003 ; Vol. 25, No. 2. pp. 47-61.
@article{68f9fc0eaf8148a0b3cd668cc564c87f,
title = "Participation and Crowd-Out in a Medicare Drug Benefit: Simulation Estimates",
abstract = "This article provides information on likely participation in the Medicare prescription drug plan and expected crowd-out. We use a microsimulation model based on data from the MCBS to estimate the costs and benefits of a Medicare drug plan, including the benefits from reductions in risk. The simulations are repeated using different combinations of benefits and subsidies. In addition, the simulations explore the effects of different behavioral parameters for moral hazard (the extent to which participants increase drug spending in response to reduced costs) and risk aversion (the extent to which participants would be willing to pay to avoid risk) to identify the impact of these factors on participation and crowd-out.",
author = "Shea, {Dennis G.} and Stuart, {Bruce C.} and Becky Briesacher",
year = "2003",
month = "12",
language = "English (US)",
volume = "25",
pages = "47--61",
journal = "Health Care Financing Review",
issn = "2159-0354",
publisher = "Centers for Medicare & Medicaid Services' Office of Research, Development & Information",
number = "2",

}

Participation and Crowd-Out in a Medicare Drug Benefit : Simulation Estimates. / Shea, Dennis G.; Stuart, Bruce C.; Briesacher, Becky.

In: Health Care Financing Review, Vol. 25, No. 2, 12.2003, p. 47-61.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Participation and Crowd-Out in a Medicare Drug Benefit

T2 - Simulation Estimates

AU - Shea, Dennis G.

AU - Stuart, Bruce C.

AU - Briesacher, Becky

PY - 2003/12

Y1 - 2003/12

N2 - This article provides information on likely participation in the Medicare prescription drug plan and expected crowd-out. We use a microsimulation model based on data from the MCBS to estimate the costs and benefits of a Medicare drug plan, including the benefits from reductions in risk. The simulations are repeated using different combinations of benefits and subsidies. In addition, the simulations explore the effects of different behavioral parameters for moral hazard (the extent to which participants increase drug spending in response to reduced costs) and risk aversion (the extent to which participants would be willing to pay to avoid risk) to identify the impact of these factors on participation and crowd-out.

AB - This article provides information on likely participation in the Medicare prescription drug plan and expected crowd-out. We use a microsimulation model based on data from the MCBS to estimate the costs and benefits of a Medicare drug plan, including the benefits from reductions in risk. The simulations are repeated using different combinations of benefits and subsidies. In addition, the simulations explore the effects of different behavioral parameters for moral hazard (the extent to which participants increase drug spending in response to reduced costs) and risk aversion (the extent to which participants would be willing to pay to avoid risk) to identify the impact of these factors on participation and crowd-out.

UR - http://www.scopus.com/inward/record.url?scp=16544362519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16544362519&partnerID=8YFLogxK

M3 - Review article

C2 - 15124377

AN - SCOPUS:16544362519

VL - 25

SP - 47

EP - 61

JO - Health Care Financing Review

JF - Health Care Financing Review

SN - 2159-0354

IS - 2

ER -